Information Session: Revolution Medicines

Information Session & Campus Recruiting

Revolution Medicines Information Session

Tuesday, November 15th | 9:30am-10:30amChemistry Gazebo
Adrian Gill – Vice President, Medicinal Chemistry
Arun Thottumkara – Scientist II, Medicinal Chemistry
Andreas Buckl – Scientist I, Medicinal Chemistry 

About Revolution Medicines:
REVOLUTION Medicines is redesigning evolution's products to treat serious diseases. The company discovers and develops new drugs by deploying our innovative product engine to reconfigure substances that are inherently rich with biological function as a result of natural selection.
 
REVOLUTION Medicines builds upon inventions by the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, who developed a transformative method for synthesizing original compounds that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive licensing agreement with the University of Illinois to practice this technology.
REVOLUTION Medicines’ product engine builds upon and expands these modular synthesis methods to power the focused and efficient assembly of simple "chemical building blocks" into refined natural product-like structures that exhibit optimized pharmacologic properties.
 
Headquartered in Redwood City, Calif., at the intersection of Silicon Valley and the birthplace of biotechnology, REVOLUTION Medicines is a private company launched with $45 million in Series A financing from Third Rock Ventures.